Ropivacaine is an aminoamide local anesthetic drug marketed by AstraZeneca under the trade name Naropin. It exists as a racemate of its S- and R-enantiomers, although the marketed form is supplied only as the purified S-enantiomer.
Ropivacaine is indicated in adult patients for the induction of regional or local anesthesia for surgery or acute pain management.
UTSW Parkland Health Hospital System, Dallas, Texas, United States
Beaumont Hospital, Royal Oak, Michigan, United States
St. Joseph's Hospital, London, Ontario, Canada
Institut Jules Bordet, Bruxelles, Belgium
Montefiore Medical Center, Bronx, New York, United States
Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, China
Ospedale San Raffaele, Milano, MI, Italy
Ospedale Regionale di Bellinzona e Valli, Bellinzona, Switzerland
Guangzhou First Municipal People's Hospital, Guangzhou, Guangdong, China
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.